Cellectricon, StressMarq Ink Neurodegenerative Disease Research Deal

Feb 04, 2020

|

NEW YORK — Cellectricon said on Tuesday that it has signed an agreement to use StressMarq Biosciences' reagents for its neurodegenerative research.

Mölndal, Sweden-based Cellectricon provides drug discovery services, with a focus on chronic pain and neurodegenerative disease. Among its areas of research is the spread of neurodegenerative disease-associated peptides, such as amyloid-beta peptides, tau, and alpha-synuclein, that characterizes Alzheimer's disease and Parkinson's disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

European Regulators Begin Review of Sputnik V

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Irish Funding Agency Seeks Boost

Science reports that Science Foundation Ireland is seeking annual budget increases.

Lower Fees Sought

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

Nature Papers Examine Peregrine Falcon Migration Patterns, Tool to Search Single-Cell Data

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.

Featured White Papers

6 Ways Phenotypic Data Improves Decision-Making in Your Drug Development Program

Discovering Multiple Pathways to Drug Resistance in Melanoma Cells with Single-Cell Proteomics and Single-Cell Metabolomics

Compatibility of Liquid Biopsy Assays on Multiple Sequencing Platforms

White Paper: Using Single-Cell Multiomics to Reveal New Insights Into Uveal Melanoma Evolution and Therapeutic Resistance

Mar

17

Featured Webinar

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Mar

24

Featured Webinar

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

This webinar, the first in a “Women in Single Cell” series sponsored by Mission Bio, will discuss the use of single-cell analysis to assess genome editing for use in pre-clinical disease modeling.

Mar

31

Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.

Apr

06

Featured Webinar

Reducing COVID-19 Infections Rates at a University Campus with Mass Screening

In this webinar session, Dr. David Harris and Dr. Ryan Sprissler, who led the student and employee testing program at University of Arizona, will discuss how the university has remained physically open with nearly 25 percent of its population on campus, while keeping infection rates below 2 percent.

Menu

Cellectricon, StressMarq Ink Neurodegenerative Disease Research Deal

To read the full story....

Breaking News

Fulgent Genetics Q4 Revenues Grow 35-Fold

T2 Biosystems Q4 Revenues Jump 152 Percent on Strong Product Sales

Datavant, Cerebral Palsy Research Network Seek Genetic Clues to CP

Finnish Population Genetic Analysis Reflects Recent Historical Events

Induced Pluripotent Stem Cells Show Potential for Finding New Regulatory Variants

C2i Genomics Acquires Sequencing Lab QNA Dx

The Scan

European Regulators Begin Review of Sputnik V

Irish Funding Agency Seeks Boost

Lower Fees Sought

Nature Papers Examine Peregrine Falcon Migration Patterns, Tool to Search Single-Cell Data

Featured White Papers

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Reducing COVID-19 Infections Rates at a University Campus with Mass Screening

What's Popular?

Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs

Sponsorships